View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

n this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Viasat Announces Comprehensive Agreement with Ligado Networks

Viasat Announces Comprehensive Agreement with Ligado Networks Viasat expects to receive $568 million from Ligado in fiscal year 2026 CARLSBAD, Calif., June 13, 2025 (GLOBE NEWSWIRE) --  (NASDAQ: VSAT), a global leader in satellite communications, today announced that its subsidiary Inmarsat Global Ltd. (“Inmarsat”) has agreed to a binding term sheet with Ligado Networks (“Ligado”) and AST & Science, LLC (“AST”) to settle Inmarsat’s opposition to Ligado’s planned restructuring. Under the conditions set forth in the term sheet, Viasat anticipates receiving $568 million from Ligado in fisc...

 PRESS RELEASE

Satélite Norte Trials Viasat Digital Bus Solution in Brazil

Satélite Norte Trials Viasat Digital Bus Solution in Brazil One of the major Brazilian bus operators has successfully completed preliminary tests and is offering Viasat’s Digital Bus solution, which provides high-speed, reliable satellite Wi-Fi to its passengers CARLSBAD, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: VSAT), a global leader in satellite communications, today announced Satélite Norte has become the first operator to trial its new Digital Bus solution allowing the major transport operator to provide high-quality passenger experiences using satellite and cellular conne...

 PRESS RELEASE

Esperion Reaches Settlement Agreement with Second ANDA Filer Not to Ma...

Esperion Reaches Settlement Agreement with Second ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) Prior to April 19, 2040 ANN ARBOR, Mich., June 02, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it has entered into a settlement agreement with Hetero USA, Inc. and its affiliates Hetero Labs Limited, Hetero Labs Limited Unit-V, and Honour Lab Limited (together, Hetero USA). This agreement resolves the patent litigation brought by Esperion against Hetero USA in response to Hetero USA’ s Abbreviated New Drug Application (ANDA) seeking approval to...

International Flavors & Fragrances Inc: 1 director

A director at International Flavors & Fragrances Inc bought 4,500 shares at 76.053USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over th...

 PRESS RELEASE

Inmarsat Provides NexusWave to Mitsui O.S.K. Lines to Help Accelerate ...

Inmarsat Provides NexusWave to Mitsui O.S.K. Lines to Help Accelerate Onboard Digitalisation Strategy Inmarsat’s fully managed bonded connectivity service will support transformation of MOL vessels into floating offices and homes to meet evolving operational and crew connectivity needs CARLSBAD, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Inmarsat Maritime, a Viasat company, has signed an agreement with Mitsui O.S.K. Lines, Ltd. (MOL) to upgrade their fleet from Fleet Xpress (FX) service to Inmarsat’s NexusWave. This fleet-wide transition to NexusWave will allow MOL to benefit from Inmarsa...

 PRESS RELEASE

Viasat Releases Fourth Quarter and Fiscal Year 2025 Financial Results

Viasat Releases Fourth Quarter and Fiscal Year 2025 Financial Results CARLSBAD, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: VSAT), a global leader in satellite communications, today published its fourth quarter and fiscal year 2025 financial results in a letter to shareholders, which, along with webcast slides, is now posted to the section of Viasat’s website. As previously announced, Viasat will host a conference call today, Tuesday, May 20, 2025 at 2:30 p.m. Pacific Time / 5:30 p.m. Eastern Time. The dial in numbers for the conference are U.S. (800) 715-9871 and International (6...

 PRESS RELEASE

Esperion to Participate in Upcoming June Investor Conferences

Esperion to Participate in Upcoming June Investor Conferences ANN ARBOR, Mich., May 20, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the following webcasted investor events during the month of June, which can be found on our investor relations . Jefferies Global Healthcare Conference in New York on June 4, 2025, at 1:25 p.m. ET. Goldman Sachs Global Healthcare Conference in Miami on June 9, 2025, at 10:40 a.m. ET. Live webcasts can be accessed on the investor and media section of the Esperion . Access to the webcast replay w...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: May 17, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Viasat and Blue Origin to Partner on Launch Telemetry Demonstration fo...

Viasat and Blue Origin to Partner on Launch Telemetry Demonstration for NASA Communications Services Project Viasat will demonstrate its InRange launch telemetry relay solution on Blue Origin’s New Glenn Rocket on two future missions CARLSBAD, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: VSAT), a global leader in satellite communications (SATCOM), today announced it has selected Blue Origin as its launch mission partner to support Viasat’s demonstration of its launch telemetry relay service as part of its work with NASA’s Communications Services Project (CSP). Viasat’s Space and M...

 PRESS RELEASE

Viasat Sets May 20, 2025 for Fourth Quarter and Fiscal Year 2025 Finan...

Viasat Sets May 20, 2025 for Fourth Quarter and Fiscal Year 2025 Financial Results Conference Call and Webcast CARLSBAD, Calif., May 13, 2025 (GLOBE NEWSWIRE) --  (NASDAQ: VSAT), a global leader in satellite communications, today announced it will release its fourth quarter and fiscal year 2025 financial results on Tuesday, May 20, 2025 after the market closes, via a letter to shareholders posted to the  section of its website. The Company will also host a conference call and webcast on Tuesday, May 20, 2025 at 2:30 p.m. Pacific Time / 5:30 p.m. Eastern Time. To participate on the live ...

 PRESS RELEASE

Viasat Selected by U.S. Space Force for Phase 2 of Enterprise Space Te...

Viasat Selected by U.S. Space Force for Phase 2 of Enterprise Space Terminal Program Viasat will continue development and testing of a new space optical terminal for crosslink communications between orbits CARLSBAD, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: VSAT), a global leader in satellite communications, today announced it was selected by the U.S. Space Force’s (USSF) Space Systems Command (SSC) for the second phase of its Enterprise Space Terminal (EST) program, which is focused on the prototyping and development of a new optical laser communications terminal that can suppo...

 PRESS RELEASE

Viasat Announces Appointments of Bill LaPlante and Michael Paull to It...

Viasat Announces Appointments of Bill LaPlante and Michael Paull to Its Board of Directors CARLSBAD, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: VSAT), a global leader in satellite communications, today announced the appointments of  Dr. William “Bill” LaPlante and Michael Paull to its Board of Directors, effective immediately. “We are delighted that Dr. LaPlante and Mr. Paull have agreed to join our Board,” said Mark Dankberg, Chairman of the Board and CEO at Viasat. “Dr. LaPlante brings a wealth of defense and national security experience, while Mr. Paull is a proven leader in th...

 PRESS RELEASE

Esperion Reaches Settlement Agreement with ANDA Filer Not to Market Ge...

Esperion Reaches Settlement Agreement with ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) Prior to April 19, 2040 ANN ARBOR, Mich., May 12, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it has entered into a settlement agreement with Micro Labs USA, Inc. and its affiliate Micro Labs Limited (together, Micro Labs). This agreement resolves the patent litigation brought by Esperion against Micro Labs in response to Micro Labs’ Abbreviated New Drug Application (ANDA) seeking approval to market a generic version of NEXLETOL prior to the expiratio...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: May 10, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

DHIL DIAMOND HILL INVESTMENT GROUP
RGR STURM RUGER & COMPANY INC.
PEB PEBBLEBROOK HOTEL TRUST
PCAR PACCAR INC
NG. NOVAGOLD RESOURCES INC.
NBTB NBT BANCORP INC.
MTX MINERALS TECHNOLOGIES INC.
MTDR MATADOR RESOURCES COMPANY
MMLP MARTIN MIDSTREAM PARTNERS L.P.
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC.
HUN HUNTSMAN CORPORATION
HL HECLA MINING COMPANY
CHDN CHURCHILL DOWNS INCORPORATED
CFFN CAPITOL FEDERAL FINANCIAL INC.
CBRL CRACKER BARREL OLD COUNTRY STORE INC.
BIIB BIOGEN INC.
APLE APPLE HOSPITALITY REIT INC
OFIX ORTHOFIX INTERNATIONAL N.V.
CAT CATERPILLAR INC.
ARCB ARCBEST CORPORATION
HTLD HEARTLAND EXPRESS INC.
USAC USA COMPRESSION PARTNERS LP
NHC NATIONAL HEALTHCARE CORP.
JELD JELD-WEN HOLDING INC.
FCNCA FIRST CITIZENS BANCSHARES INC. CLASS A
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
OCSL OAKTREE SPECIALTY LENDING CORPORATION
SNBR SLEEP NUMBER CORPORATION
RCII RENT-A-CENTER INC
A2H9KJ NEO PERFORMANCE MATERIAL
KKR KKR & CO. INC.
REZI RESIDEO TECHNOLOGIES
TROX INC.
UTGN TRONOX HOLDINGS PLC
CCO UTG
AVTR CLEAR CHANNEL OUTDOOR HOLDINGS INC
GCI AVANTOR
DCTH INC.
ONEW GANNETT CO. INC.
DLHC DELCATH SYSTEMS
UTZ ONEWATER MARINE
OGN DALEIGH HOLDINGS CORP
NVCT UTZ BRANDS INC (A)
PRAA ORGANON & CO
VSTS_w NUVECTIS PHARMA INC
BNL PORTFOLIO RECOVERY ASSOCIATES
DMA INC.
SUNS VESTIS CORPORATION
GF BROADSTONE NET LEASE INC
FG DESTRA MULTI ALTERNATIVE FUND
EU SUNRISE REALTY TRUST
ECF THE NEW GERMANY FUND
HCWB INC.
F AND G ANNUITIES AND LIFE
INC.
WISDOMTREE EURO DEBT FUND
ELLSWORTH FUND LTD
HCW BIOLOGICS INC
 PRESS RELEASE

Esperion to Participate in H.C. Wainwright’s 3rd Annual BioConnect Inv...

Esperion to Participate in H.C. Wainwright’s 3rd Annual BioConnect Investor Conference ANN ARBOR, Mich., May 09, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the webcasted H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20, 2025, at 10 a.m. ET. The live webcast can be accessed on the investor and media section of the Esperion . Access to the webcast replay will be available approximately two hours after the completion of the call and will be archived on the Company’s website for approximately 90 days. Esperio...

 PRESS RELEASE

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)...

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) ANN ARBOR, Mich., May 08, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on May 7, 2025, the Company granted 15 new employees 49,300 restricted stock units (RSUs) under Esperion’s 2017 Inducement Equity Incentive Plan. The 2017 Inducement Equity Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of Esperion (or following a bona fide period of non-employment), as an inducement material to such individual...

 PRESS RELEASE

Esperion Partners with HLS Therapeutics to Commercialize NEXLETOL® (be...

Esperion Partners with HLS Therapeutics to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Canada – Esperion to Receive an Upfront Payment, Near-Term Milestones and Tiered Royalties on Product Sales – – Further Expands Global Access to Bempedoic Acid Products and Provides Opportunity to Bring Innovative Preventative Therapy to 2.6 million Canadians Living with Diagnosed Heart Disease – ANN ARBOR, Mich., May 08, 2025 (GLOBE NEWSWIRE) -- Esperion Therapeutics (NASDAQ: ESPR) today announced it has entered into a license and distribution agreement wi...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch